Literature DB >> 11266729

CD8(+)CD28(-) T suppressor cells represent a distinct subset in a heterogeneous population.

A I Colovai1, R Ciubotariu, Z Liu, R Cortesini, N Suciu-Foca.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11266729     DOI： 10.1016/s0041-1345(00)01927-8

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.

Authors:  Elena Gonzalez-Rey; Alejo Chorny; Amelia Fernandez-Martin; Doina Ganea; Mario Delgado
Journal:  Blood       Date:  2006-01-05       Impact factor: 22.113

2.  TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs.

Authors:  Brygida Bisikirska; John Colgan; Jeremy Luban; Jeffrey A Bluestone; Kevan C Herold
Journal:  J Clin Invest       Date:  2005-09-15       Impact factor: 14.808

Review 3.  CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease.

Authors:  Marius Strioga; Vita Pasukoniene; Dainius Characiejus
Journal:  Immunology       Date:  2011-06-29       Impact factor: 7.397

4.  Autoreactive responses to an environmental factor. 2. Phthalate-induced anti-DNA specificity is downregulated by autoreactive cytotoxic T cells.

Authors:  So-Yon Lim; Swapan K Ghosh
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

Review 5.  Treatment of type 1 diabetes with anti-CD3 monoclonal antibody.

Authors:  Mariela Glandt; William Hagopian; Kevan C Herold
Journal:  Rev Endocr Metab Disord       Date:  2003-12       Impact factor: 9.306

6.  Mesenchymal stem cell as salvage treatment for refractory chronic GVHD.

Authors:  J Y Weng; X Du; S X Geng; Y W Peng; Z Wang; Z S Lu; S J Wu; C W Luo; R Guo; W Ling; C X Deng; P J Liao; A P Xiang
Journal:  Bone Marrow Transplant       Date:  2010-09-06       Impact factor: 5.483

7.  Ex Vivo Expanded Human Non-Cytotoxic CD8+CD45RClow/- Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized Mice.

Authors:  Séverine Bézie; Dimitri Meistermann; Laetitia Boucault; Stéphanie Kilens; Johanna Zoppi; Elodie Autrusseau; Audrey Donnart; Véronique Nerrière-Daguin; Frédérique Bellier-Waast; Eric Charpentier; Franck Duteille; Laurent David; Ignacio Anegon; Carole Guillonneau
Journal:  Front Immunol       Date:  2018-01-31       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.